Trial intelligence / Profile preview

OCP plus vitamin D3 for sexual dysfunction in women with PCOS

IRCT20150905023897N3Phase 3Completed

Sponsor
Tarbiat Modares University
Start
Jan 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in female sexual dysfunction (FSD) comparing OCP + vitamin D3 with Placebo + vitamin D3 (2 arms). Started Jan 2019; status: completed.

02

Drugs

vitamin d
03

Conditions

female sexual dysfunction (FSD)

Beyond the preview

Go deeper on IRCT20150905023897N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150905023897N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call